The Movement Disorder Clinic of Oklahoma

Tulsa, Oklahoma 74137

6 studies enrolling now · 26 studies all time

What they study most

Akinesia, Constipation, Deep Brain Stimulation, Delayed Levodopa Onset, Early Parkinson Disease, Early Parkinson Disease (Early PD), Hypomobility, Idiopathic Parkinson Disease, Lewy Body Dementia Psychosis, Motor Symptoms, Multiple System Atrophy, Parkinson

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease — Recruiting now
• A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease — Recruiting now
• Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis — Recruiting now
• A Study of Buntanetap in Participants With PD — Recruiting now
• A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease — Recruiting now
• Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis — Enrolling by invitation
• A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease — Running, not enrolling
• To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications — Running, not enrolling
• PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706 — Stopped early
• A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease — Running, not enrolling
• Study of ATH434 in Participants with Multiple System Atrophy — Completed
• A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease. — Completed
• A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease — Completed
• A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis — Completed
• A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia — Completed
• Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET) — Completed
• Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease — Completed
• Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) — Completed
• Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide) — Completed
• Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations — Stopped early
• Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease — Completed
• An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease — Completed
• A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients — Status unconfirmed
• Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations — Stopped early
• A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004 — Status unconfirmed